HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: thx.2005.041913v1 60/11/902    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gyllfors, P Articles by Dahlén, B Search for Related Content PubMed PubMed Citation Articles by Gyllfors, P Articles by Dahlén, B

Relation between bronchial responsiveness to inhaled leukotriene D₄ and markers of leukotriene biosynthesis

¹ Division of Respiratory Medicine, Department of Medicine at Karolinska University Hospital Solna, Centre for Allergy Research at Karolinska Institutet, Stockholm, Sweden
² Division of Physiology, The National Institute of Environmental Medicine, Centre for Allergy Research at Karolinska Institutet, Stockholm, Sweden
³ Family Medicine Stockholm, Department of Clinical Science, Centre for Allergy Research at Karolinska Institutet, Stockholm, Sweden
⁴ Division of Respiratory Medicine, Department of Medicine at Karolinska University Hospital Huddinge, Centre for Allergy Research at Karolinska Institutet, Stockholm, Sweden

Correspondence to:
Correspondence to:
Dr B Dahlén
Division of Respiratory Medicine, Department of Medicine, Karolinska University Hospital Huddinge, SE-141 46 Stockholm, Sweden; Barbro.dahlen{at}medhs.ki.se

Background: While clinical trials with antileukotrienes have shown overall beneficial effects in asthma, the factors that determine leukotriene dependent asthma are still unclear. A study was undertaken to determine whether or not leukotriene responsiveness in the airways correlates with endogenous leukotriene biosynthesis.

Methods: Bronchial responsiveness to leukotriene (LT) D₄ was assessed as PD₂₀FEV₁ in 20 subjects with mild asthma and 10 healthy controls, and compared with bronchial responsiveness to methacholine and two global measures of leukotriene production—urinary LTE₄ and ex vivo production of LTB₄ in whole blood.

Results: In patients with asthma the bronchoconstrictor activity of LTD₄ was about 1300 times greater than methacholine (geometric mean PD₂₀ 0.69 nmol v 887 nmol). Those who were most responsive to LTD₄ were relatively less responsive to methacholine (p<0.01). There was, however, no correlation between bronchial responsiveness to LTD₄ and urinary LTE₄ or blood ex vivo LTB₄ levels in asthmatic subjects or healthy controls. Subjects with asthma treated with inhaled corticosteroids produced higher levels of LTB₄ (p<0.05).

Conclusions: General measures of leukotriene production cannot predict bronchial responsiveness to LTD₄. The unique bronchoconstrictive potency of LTD₄ on human airways may relate to the locally regulated expression of the cysteinyl LT₁ receptor.

Abbreviations: CysLT, cysteinyl leukotriene; FEV₁, forced expiratory volume in 1 second; FeNO, fractional exhaled nitric oxide; ICS, inhaled corticosteroids; MCh, methacholine; PD₁₀, PD₁₅, PD₂₀, provocative dose causing a 10%, 15% and 20% decrease in FEV₁

Keywords: asthma; bronchial responsiveness; leukotrienes

This article has been cited by other articles:

				F Gaber, K Daham, A Higashi, N Higashi, A Gulich, I Delin, A James, M Skedinger, P Gyllfors, M Nord, et al. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma Thorax, December 1, 2008; 63(12): 1076 - 1082. [Abstract] [Full Text] [PDF]

				M. Muller, J. Grunewald, C. Olgart Hoglund, B. Dahlen, A. Eklund, and H. Stridh Altered apoptosis in bronchoalveolar lavage lymphocytes after allergen exposure of atopic asthmatic subjects Eur. Respir. J., September 1, 2006; 28(3): 513 - 522. [Abstract] [Full Text] [PDF]